ALLI
orlistat
- Strength
- 60 mg/1
- Form
- Capsule
- Class
- Intestinal Lipase Inhibitor
Haleon US Holdings LLC
Listed by H2-Pharma LLC
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Intestinal Lipase Inhibitor |
| Approval route | Authorised generic |
| NDC code | 61269-565 |
| FDA application | NDA020766 |
| RxNorm concept | 314153 |
| Package sizes listed | 1 |
| Marketed since | June 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
orlistat
Haleon US Holdings LLC
orlistat
Aphena Pharma Solutions - Tennessee, LLC
orlistat
H2-Pharma LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.